Ebiotec is a leading Spanish company founded in 2001, devoted to the research and development of innovative nutraceuticals and high-technology services targeted to enhancing human health and nutrition, which aid health professionals in the early diagnosis, prevention and personalized treatment of disease.



Ebiotec is organized in different specialized areas in order to obtain the best results:

In the NUTRACEUTICALS DIVISION, our efforts focus on the research and development of scientifically proven food supplements of vegetal and marine origin, the latter being the result of extensive research on marine bioprospecting.

In the CLINICAL GENETICS AREAS, our interest lies in the research and development of the genetics of complex disorders; here we market a range of genetic susceptibility panels; and also in human identification genetics.

In the GENOMICS AND PHARMAGENOMICS UNIT, one of our major areas, we conduct primary screening of new products as well as basic & clinical pharmacogenomic studies applied to priority problems in biomedicine.

In the BIOTECHNOLOGY DIVISION, our research is mainly focused on immunogenics and its optimal application in the effective diagnosis of biochemical imbalances caused by food intolerances and allergies.